...
首页> 外文期刊>Cancer investigation >Clinically Relevant Quality Assurance for Intensity Modulated Radiotherapy Plans: Gamma Maps and DVH-Based Evaluation
【24h】

Clinically Relevant Quality Assurance for Intensity Modulated Radiotherapy Plans: Gamma Maps and DVH-Based Evaluation

机译:调强放疗计划的临床相关质量保证:伽玛图和基于DVH的评估

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To explore a novel patient-dose DVH-based method for pretreatment dose quality assurance tests. Methods: 20 IMRT plans for head-and-neck cancer patients were used. A comparison was performed between the planned dose distributions, the computed, and the reconstructed ones using the gamma-index (GI) method. The GI analysis was performed using both the 3%/3 mm and the 2%/2mm criteria. Results: No significant DVH- deviation was observed. Considering the 3%/3 mm criteria the mean GI% < 1 for the body and structures was significantly higher compared to 2%/2 mm criteria. Conclusions: Our results underline the importance of QA-methods based on DVH-metrics to predict the impact of delivered dose.
机译:目的:探索一种基于患者剂量DVH的新型方法进行预处理剂量质量保证测试。方法:针对头颈癌患者使用了20份IMRT计划。使用伽玛指数(GI)方法在计划的剂量分布,计算的和重构的剂量分布之间进行比较。 GI分析使用3%/ 3 mm和2%/ 2mm标准进行。结果:未观察到明显的DVH-偏差。考虑到3%/ 3 mm标准,与2%/ 2 mm标准相比,身体和结构的平均GI%<1显着更高。结论:我们的结果强调了基于DVH指标的质量保证方法对预测给药剂量的影响的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号